Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tilman Werner

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Pathologie (Heidelberg, Germany)|November 7, 2024
Advancements in mass spectrometry-based proteomics: a new era in pathology research and diagnosticsTilman Werner, Matthias Fahrner, Oliver Schilling
Pathologie (Heidelberg, Germany)|November 24, 2023
Using proteomics for stratification and risk prediction in patients with solid tumorsTilman Werner, Matthias Fahrner, Oliver Schilling
Clinical Proteomics|January 24, 2026
ProteoBoostR: an interactive framework for supervised machine learning in clinical proteomicsAnnika Topitsch, Niko Pinter, Tilman Werner, et al.
Journal of Cancer|January 2, 2025
Impact of ALDH1A1 Expression in Intrahepatic Cholangiocellular CarcinomaKonrad Kurowski, Melanie Föll, Tilman Werner, et al.
Nature Communications|March 24, 2026
Proteomic characterization of intrahepatic cholangiocarcinoma identifies risk-stratifying subgroups and EIF4A1 as a therapeutic targetTilman Werner, Johanna Thiery, Klara-Luisa Budau, et al.
The Journal of Pathology|November 25, 2024
Proteomic analysis of non-muscle invasive and muscle invasive bladder cancer highlights distinct subgroups with metabolic, matrisomal, and immune hallmarks and emphasizes importance of the stromal compartmentThien-Ly Julia Dinh, Manuel Rogg, Miguel Cosenza-Contreras, et al.
Neuro-Oncology|October 26, 2023
Proteometabolomics of initial and recurrent glioblastoma highlights an increased immune cell signature with altered lipid metabolismMiguel Cosenza-Contreras, Agnes Schäfer, Justin Sing, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Pathologie (Heidelberg, Germany)|November 7, 2024
Advancements in mass spectrometry-based proteomics: a new era in pathology research and diagnosticsTilman Werner, Matthias Fahrner, Oliver Schilling
Pathologie (Heidelberg, Germany)|November 24, 2023
Using proteomics for stratification and risk prediction in patients with solid tumorsTilman Werner, Matthias Fahrner, Oliver Schilling
Clinical Proteomics|January 24, 2026
ProteoBoostR: an interactive framework for supervised machine learning in clinical proteomicsAnnika Topitsch, Niko Pinter, Tilman Werner, et al.
Journal of Cancer|January 2, 2025
Impact of ALDH1A1 Expression in Intrahepatic Cholangiocellular CarcinomaKonrad Kurowski, Melanie Föll, Tilman Werner, et al.
Nature Communications|March 24, 2026
Proteomic characterization of intrahepatic cholangiocarcinoma identifies risk-stratifying subgroups and EIF4A1 as a therapeutic targetTilman Werner, Johanna Thiery, Klara-Luisa Budau, et al.
The Journal of Pathology|November 25, 2024
Proteomic analysis of non-muscle invasive and muscle invasive bladder cancer highlights distinct subgroups with metabolic, matrisomal, and immune hallmarks and emphasizes importance of the stromal compartmentThien-Ly Julia Dinh, Manuel Rogg, Miguel Cosenza-Contreras, et al.
Neuro-Oncology|October 26, 2023
Proteometabolomics of initial and recurrent glioblastoma highlights an increased immune cell signature with altered lipid metabolismMiguel Cosenza-Contreras, Agnes Schäfer, Justin Sing, et al.
Pageof 1